New genetic vaccines using self-replicative RNA The discovery that naked plasmid DNA can elicit humoral and cellular immunity has prompted the development of genetic vaccines against many viruses for which no prevention currently exists. In the 1 May Journal of Infectious Diseases, Marina Fleeton and colleagues from the Karolinska Institute in Stockholm suggest the possibility of using the recombinant alpha virus RNA molecule -which replicates in the cytoplasm of transfected cells -as a novel approach in genetic vaccine development. In contrast to the viral vector approach the rSFV RNA vaccine contains none of the highly immunogenic viral structural components. This may be of considerable benefit in situations where booster immunizations are desired.
